| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |